Remimazolam to prevent irregular heartbeat after heart surgery
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether a medication called remimazolam can help prevent atrial fibrillation—a common, irregular heart rhythm that can happen after surgery. It focuses on people having a specific planned type of heart bypass surgery and checks if the study medication reduces postoperative rhythm problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 50 to 70 years old
- Have a body mass index (BMI) between 18 and 28
- Be scheduled for planned selective CABG (heart bypass) surgery at the study hospital in Yangzhou, China
- Have no irregular fast heart rhythm (supraventricular arrhythmia) before surgery
- You must agree to take part and sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
This study tests whether a sedation drug called remimazolam can help protect your kidneys during liver or pancreas surgery. If you are having one of these surgeries, you might be able to join.
This study tests whether a sedative called remimazolam can help protect the heart during surgery in older adults. If you are 65 or older and having a longer surgery with general anesthesia, this trial may be for you.
This trial compares two types of sedation for older adults recovering from heart bypass surgery in the ICU. It aims to see which drug keeps your heart function more stable while you are on a breathing machine.
This trial tests if a sedative called remimazolam can reduce confusion or delirium in older adults after laparoscopic stomach surgery. If you are at least 65 years old and scheduled for this surgery, you may be eligible.
This trial tests a new sedative called remimazolam for people having planned heart surgery with a heart-lung machine. It aims to see if it works well and is safe for keeping you asleep during the operation.
Hear when a new Coronary Artery Bypass Grafting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.